430 related articles for article (PubMed ID: 18088560)
41. The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions.
Naef M; Curatolo M; Petersen-Felix S; Arendt-Nielsen L; Zbinden A; Brenneisen R
Pain; 2003 Sep; 105(1-2):79-88. PubMed ID: 14499423
[TBL] [Abstract][Full Text] [Related]
42. Intravenous ketorolac and subarachnoid opioid analgesia in the management of acute postoperative pain.
Gwirtz KH; Kim HC; Nagy DJ; Young JV; Byers RS; Kovach DA; Li W
Reg Anesth; 1995; 20(5):395-401. PubMed ID: 8519716
[TBL] [Abstract][Full Text] [Related]
43. Hydrocodone/acetaminophen and tramadol chlorhydrate combination tablets for the management of chronic cancer pain: a double-blind comparative trial.
Rodriguez RF; Castillo JM; Castillo MP; Montoya O; Daza P; Rodríguez MF; Restrepo JM; León ME; Angel AM
Clin J Pain; 2008 Jan; 24(1):1-4. PubMed ID: 18180628
[TBL] [Abstract][Full Text] [Related]
44. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial.
Stockler M; Vardy J; Pillai A; Warr D
J Clin Oncol; 2004 Aug; 22(16):3389-94. PubMed ID: 15310785
[TBL] [Abstract][Full Text] [Related]
45. A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain.
Beaulieu AD; Peloso P; Bensen W; Clark AJ; Watson CP; Gardner-Nix J; Thomson G; Piraino PS; Eisenhoffer J; Harsanyi Z; Darke AC
Clin Ther; 2007 Jan; 29(1):49-60. PubMed ID: 17379046
[TBL] [Abstract][Full Text] [Related]
46. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
[TBL] [Abstract][Full Text] [Related]
47. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
Younger J; Noor N; McCue R; Mackey S
Arthritis Rheum; 2013 Feb; 65(2):529-38. PubMed ID: 23359310
[TBL] [Abstract][Full Text] [Related]
48. [The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain].
Clermont-Gnamien S; Atlani S; Attal N; Le Mercier F; Guirimand F; Brasseur L
Presse Med; 2002 Nov; 31(39 Pt 1):1840-5. PubMed ID: 12496714
[TBL] [Abstract][Full Text] [Related]
49. Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability.
de Vries M; Van Rijckevorsel DC; Vissers KC; Wilder-Smith OH; Van Goor H
Br J Clin Pharmacol; 2016 Mar; 81(3):525-37. PubMed ID: 26505163
[TBL] [Abstract][Full Text] [Related]
50. Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: a randomized controlled trial.
Ahmed AI; van den Elsen GA; Colbers A; van der Marck MA; Burger DM; Feuth TB; Rikkert MG; Kramers C
Eur Neuropsychopharmacol; 2014 Sep; 24(9):1475-82. PubMed ID: 25035121
[TBL] [Abstract][Full Text] [Related]
51. Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain.
Lichtman AH; Lux EA; McQuade R; Rossetti S; Sanchez R; Sun W; Wright S; Kornyeyeva E; Fallon MT
J Pain Symptom Manage; 2018 Feb; 55(2):179-188.e1. PubMed ID: 28923526
[TBL] [Abstract][Full Text] [Related]
52. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial.
Ellis RJ; Toperoff W; Vaida F; van den Brande G; Gonzales J; Gouaux B; Bentley H; Atkinson JH
Neuropsychopharmacology; 2009 Feb; 34(3):672-80. PubMed ID: 18688212
[TBL] [Abstract][Full Text] [Related]
53. A Secondary Analysis from a Randomized Trial on the Effect of Plasma Tetrahydrocannabinol Levels on Pain Reduction in Painful Diabetic Peripheral Neuropathy.
Wallace MS; Marcotte TD; Atkinson JH; Padovano HT; Bonn-Miller M
J Pain; 2020; 21(11-12):1175-1186. PubMed ID: 32565122
[TBL] [Abstract][Full Text] [Related]
54. Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study.
Rintala DH; Fiess RN; Tan G; Holmes SA; Bruel BM
Am J Phys Med Rehabil; 2010 Oct; 89(10):840-8. PubMed ID: 20855984
[TBL] [Abstract][Full Text] [Related]
55. [Dronabinol (delta9-tetrahydrocannabinol) in long-term treatment. Symptom control in patients with multiple sclerosis and spasticity, neuropathic pain, loss of appetite and cachexia].
Nauck F; Klaschik E
Schmerz; 2004 Dec; 18 Suppl 2():S26-30. PubMed ID: 23570087
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy.
Wallace MS; Marcotte TD; Umlauf A; Gouaux B; Atkinson JH
J Pain; 2015 Jul; 16(7):616-27. PubMed ID: 25843054
[TBL] [Abstract][Full Text] [Related]
57. Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humans.
Babalonis S; Lofwall MR; Sloan PA; Nuzzo PA; Fanucchi LC; Walsh SL
Psychopharmacology (Berl); 2019 Nov; 236(11):3341-3352. PubMed ID: 31201479
[TBL] [Abstract][Full Text] [Related]
58. Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain.
Campbell CM; Mun CJ; Hamilton KR; Bergeria CL; Huhn AS; Speed TJ; Vandrey R; Dunn KE
Neuropsychopharmacology; 2023 Oct; 48(11):1630-1638. PubMed ID: 37202479
[TBL] [Abstract][Full Text] [Related]
59. [Delta(9)-tetrahydrocannabinol and the opioid receptor agonist piritramide do not act synergistically in postoperative pain].
Seeling W; Kneer L; Büchele B; Gschwend JE; Maier L; Nett C; Simmet T; Steffen P; Schneider M; Rockemann M
Anaesthesist; 2006 Apr; 55(4):391-400. PubMed ID: 16389542
[TBL] [Abstract][Full Text] [Related]
60. In an exploratory randomized, double-blind, placebo-controlled, cross-over study, psychoactive doses of intravenous delta-9-tetrahydrocannabinol fail to produce antinociceptive effects in healthy human volunteers.
Schindler EAD; Schnakenberg Martin AM; Sewell RA; Ranganathan M; DeForest A; Pittman BP; Perrino A; D'Souza DC
Psychopharmacology (Berl); 2020 Oct; 237(10):3097-3107. PubMed ID: 32632491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
